Abstract P037: A phase 1/2 dose escalation and expansion study of OP-1250 in adults with advanced and/or metastatic hormone receptor-positive (HR+), HER2-negative (HER2−) breast cancer
Alemany, Carlos, Patel, Manish, Mitri, Zahi, Sparano, Joseph, Borges, Virginia, Makower, Della, Klein, Pam, Lawrence, Julia, Le, Trinh, Zujewski, Jo Anne, Harmilton, Erika
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article